Investor Relations Factbook 2012

Transcription

1 Investor Relations Factbook 2012

2 Table of Contents Page 3 Drugstore Count 4 Revenue Per Drugstore 5 Employee Count 6 Revenue 7 Gross Profit 8 Cost of Goods Sold 9 Selling, General and Administrative Expenses 10 Net Income 11 Diluted Earnings Per Share 12 Dividends 13 Cash Returned to Shareholders 14 Total Comparable Store Sales 15 Rx Comparable Store Sales 16 Front End Comparable Store Sales (Quarterly) 17 Front End Comparable Store Sales (Annual) 18 Comparable Store Prescriptions Filled (Quarterly) 19 Comparable Store Prescriptions Filled (Annual) 20 Retail Prescription Market Share 21 Total Prescriptions Filled 22 Generic Utilization Rates 23 Total Prescription Sales Dollars 24 Total Prescriptions / Drugstore / Day 25 LIFO Inventory vs. FIFO Inventory 26 LIFO Inventory per Drugstore 27 Total Capital Expenditures 28 Total Invested Capital 29 Return on Average Invested Capital 30 Free Cash Flow 31 Annual Stock Price (FY 1995 Q1 FY 2011) 32 Monthly Stock Price (FY 2000 FY 2005) 33 Monthly Stock Price (FY 2006 FY 2011) Walgreen Co

3 Total Drugstores YOY % Growth Drugstore Count 8,000 15% 7,000 6,000 5, ,000 3,000 2,000 5% 1,000 0 Total Drugstores 3,520 3,880 4,224 4,579 4,950 5,415 5,885 6,443 6,997 7,562 7,761 YOY % Growth 11.2% 10.2% 8.9% 8.4% 8.1% 9.4% 8.7% 9.5% 8.6% 8.1% 2.6% Free Standing % 84% 85% 86% 87% 88% 85% 85% 24 Hour 23% 23% 26% 3 31% 29% 28% 25% 23% 21% 21% 1 Hour Photo 98% 98% 98% 99% 99% 98% 97% 97% 97% 94% 93% Drive-Thru 78% 78% 78% 8 82% 84% 85% 86% 87% 85% 84% Walgreen Co

4 Revenue per Drugstore ($ in Thousands) YOY % Growth Revenue per Drugstore 10, ,000 8,000 15% 7,000 6, ,000 4,000 5% 3,000 2,000 1,000 0 Rev. / Drugstore 6,995 7,392 7,695 8,191 8,526 8,755 9,135 9,163 9,052 8,916 9,301 YOY % Growth 4.4% 5.7% 4.1% 6.4% 4.1% 2.7% 4.3% 0.3% -1.2% -1.5% 4.3% -5% Walgreen Co

5 Number of Employees YOY % Growth Employee Count 300, ,000 18% 16% 14% 200, , ,000 50,000 0 # of Employees 129, , , , , , , , , , ,000 YOY % Growth 11.2% 9.3% 9.2% 5.8% 9.8% 8.9% 15.9% 4.9% 0.4% 2.5% 1.2% 12% 1 8% 6% 4% 2% Walgreen Co

6 Revenue ($ in Millions) YOY % Growth Revenue 80, ,000 60,000 15% 50,000 40, ,000 20,000 5% 10,000 0 Revenue 24,623 28,681 32,505 37,508 42,202 47,409 53,762 59,034 63,335 67,420 72,184 YOY % Growth 16.1% 16.5% 13.3% 15.4% 12.5% 12.3% 13.4% 9.8% 7.3% 6.4% 7.1% Walgreen Co

7 Gross Profit ($ in Millions) YOY % Growth Gross Profit 25, ,000 15% 15, ,000 5,000 5% 0 Gross Profit 6,574 7,605 8,799 10,198 11,788 13,169 15,244 16,643 17,613 18,976 20,492 YOY % Growth 14.5% 15.7% 15.7% 15.9% 15.6% 11.7% 15.8% 9.2% 5.8% 7.7% 8. Margin 26.7% 26.5% 27.1% 27.2% 27.9% 27.8% 28.4% 28.2% 27.8% 28.1% 28.4% Walgreen Co

8 COGS ($ in Millions) YOY % Growth Cost of Goods Sold 60, ,000 15% 40,000 30, ,000 5% 10,000 0 COGS 18,049 21,076 23,706 27,310 30,414 34,240 38,518 42,391 45,722 48,444 51,692 YOY % Growth 16.7% 16.8% 12.5% 15.2% 11.4% 12.6% 12.5% 10.1% 7.9% % % of Sales 73.3% 73.5% 72.9% 72.8% 72.1% 72.2% 71.6% 71.8% 72.2% 71.9% 71.6% Walgreen Co

9 SG&A ($ in Millions) YOY % Growth Selling, General and Administrative Expenses 20, ,000 15% 10, ,000 5% 0 SG&A 5,171 5,993 6,938 8,055 9,364 10,467 12,093 13,202 14,366 15,518 16,561 YOY % Growth 14.9% 15.9% 15.8% 16.1% 16.2% 11.8% 15.5% 9.2% 8.8% % % of Sales % 21.3% 21.5% 22.2% 22.1% 22.5% 22.4% 22.7% % Walgreen Co

10 Net INcome ($ in Millions) YOY % Growth Net Income 3, % 2, % 1 1,000 5% -5% 0 Net Income 875 1,008 1,165 1,350 1,560 1,751 2,041 2,157 2,006 2,091 2,714 YOY % Growth 14.2% 15.2% 15.6% 15.9% 15.5% 12.3% 16.6% 5.7% % 29.8% Profit Margin 3.6% 3.5% 3.6% 3.6% 3.7% 3.7% 3.8% 3.7% 3.2% 3.1% 3.8% * -1 * Adjusted NI = $2,441 excluding sale of WHI. YOY% Growth = 16.7%. Net Margin = 3.4%. Walgreen Co

11 Earnings Per Share YOY % Growth Diluted Earnings Per Share $ $ % 3 $ % $ % $ $1.00 5% $0.50-5% $0.00 EPS Diluted YOY % Growth 13.2% 14.9% 15.7% % % -6.9% % Dil. Avg. Shares * -1 * Adjusted EPS Diluted = $2.64 excluding sale of WHI. YOY% Growth = 24.5%. Walgreen Co

12 Dividends Declaired Per Share YOY % Growth Dividends $1.0 3 $0.8 25% $0.6 $ % 1 $0.2 5% $0.0 Dividends Declared YOY % Growth 3.6% 3.4% % 23.8% 19.2% 22.6% 18.4% 22.2% 27.3% 28.6% Payout Ratio 16.1% 14.6% 13.1% 13.1% 13.8% % 17.4% 22.2% 25.9% 23.8% Dividends Paid $141 $147 $152 $177 $215 $263 $310 $376 $446 $541 $647 Walgreen Co

13 Cash Returned to Shareholders ($ in Millions) YOY % Growth Cash Returned to Shareholders 3, , , , , Cash Returned $141 $147 $152 $199 $560 $553 $998 $376 $446 $2,181 $2,431 YOY % Growth 4.7% 4.3% 3.7% 30.5% 181.3% -1.2% 80.5% -62.3% 18.6% % Dividends $141 $147 $152 $177 $215 $263 $310 $376 $446 $541 $647 Repurchases $- $- $- $22 $345 $290 $688 $- $- $1,640 $1, Walgreen Co

14 Total Sales Comp Total Comparable Store Sales 12% 1 8% 6% 4% 2% Total Sales Comp 10.5% 10.5% 8.6% 10.9% 8.2% 7.7% 8.1% % 3.3% Walgreen Co

15 Rx Sales Comp Rx Comparable Store Sales 2 18% 16% 14% 12% 1 8% 6% 4% 2% Rx Sales Comp 17.6% 16.3% 13.2% % 9.2% 9.5% 3.9% 3.5% 2.3% 3.3% Walgreen Co

16 FE Sales Comp Front End Comparable Store Sales (Quarterly) 5% 4% 3% 2% 1% -1% -2% Q3 09 Q4 09 Q1 10 Q2 10 Q3 10 Q4 10 Q1 11 Q2 11 Q3 11 Q4 11 Q1 12 Q2 12 FE Comp 0.9% -1.4% 2.7% -1.6% 0.1% 1.2% 0.4% 4.3% 3.9% 4.6% 2.4% 1.2% Walgreen Co

17 FE Sales Comp Front End Comparable Store Sales (Annual) 7% 6% 5% 4% 3% 2% 1% -1% FE Comp 2.2% % 5.5% 5.3% 5.8% 4.2% -0.5% 0.5% 3.3% Walgreen Co

18 Rx Script Comp Comparable Store Prescriptions Filled (Quarterly) 1 8% 6% 4% 2% -2% -4% -6% -8% Q3 09 Q4 09 Q1 10 Q2 10 Q3 10 Q4 10 Q1 11 Q2 11 Q3 11 Q4 11 Q1 12 Q2 12 Rx Script Comp 5.1% 5.9% 9.2% 3.4% 2.5% 3.3% % 4.6% 3.4% 1.8% -6.1% *All figures are 90-Day Adjusted Walgreen Co

19 Rx Script Comp Comparable Store Prescriptions Filled (Annual) 8% 7% 6% 5% 4% 3% 2% 1% Rx Script Comp 6.9% 4.9% 5.7% 2.8% 3.6% 4.5% 3.7% Walgreen Co

20 Retail Prescription Market Share Retail Prescription Market Share 25% 2 15% 1 5% Retail Rx % 15.3% 16.3% 18.1% 18.2% 18.9% 19.5% 20. Walgreen Co

21 Prescription Count (# in thousands) YOY % Growth Total Prescription Filled 900, , , , ,000 14% 12% 1 8% 400, , , ,000 6% 4% 2% 0 Total Scripts 322, , , , , , , , , , ,000 YOY % Growth % 10.7% 10.8% 10.5% 8.3% 10.1% 6.4% 6.8% 7.6% 5.3% *Beginning in 2007, all scripts are 90-Day adjusted Walgreen Co

22 Generic Utilization Rates Generic Utilization Rates Utilitzation 45.7% % 52.4% 56.4% 59.3% 62.9% 66.6% 69.9% 72.5% 75.6% Walgreen Co

23 Total Prescription Sales YOY % Growth Total Prescription Sales Dollars 50,000 45,000 40,000 35,000 30,000 25,000 20,000 15,000 10,000 5, % 2 15% 1 5% 0 Total Prescription Sales 14,158 17,209 20,153 23,705 26,882 30,484 34,945 38,313 41,358 43,958 46,703 YOY % Growth 20.9% 21.5% 17.1% 17.6% 13.4% 13.4% 14.6% 9.6% 7.9% 6.3% 6.2% % of Total 57.5% % 63.7% 64.3% % 65.3% 65.2% 64.7% Walgreen Co

24 Rx / Drugstore / Day YOY % Growth Total Prescriptions / Drugstore / Day 350 8% 300 6% 250 4% 200 2% % 0 Rx / Drugstore / Day YOY % Growth 0.7% 1.4% 1.7% 2.2% 2.2% % % -0.4% 2.6% -4% Walgreen Co

25 LIVO vs. FIFO IInventory ($ in Millions) LIFO Inventory vs. FIFO Inventory 12,000 10,000 8,000 6,000 4,000 2,000 0 FIFO Inventory 4,120 4,339 4,932 5,475 6,397 6,950 7,759 8,316 8,028 8,757 9,632 LIFO Inventory 3,482 3,645 4,203 4,739 5,593 6,050 6,791 7,249 6,789 7,378 8,044 LIFO Reserve ,067 1,239 1,379 1,588 LIFO Provision Walgreen Co

26 LIFO Inventory per Drugstore ($ in Thousands) YOY % Growth LIFO Inventory per Drug Store 1,400 15% 1, , % -5% -1 LIFO Inv. / Drugstore ,035 1,130 1,117 1,154 1, ,036 YOY % Growth 10.6% % % -1.1% 3.3% -2.5% -13.8% 0.6% 6.2% -15% Walgreen Co

27 Capital Expenditures ($ in Millions) YOY % Growth Total Capital Expenditures $2,500 4 $2,000 2 $1,500 $1,000-2 $500-4 $0 Capital Expenditures 1, ,238 1,338 1,785 2,225 1,927 1,014 1,213 YOY % Growth 10.5% -24.5% -14.9% 18.2% 31.7% 8.1% 33.5% 24.6% -13.4% -47.4% 19.6% -6 Walgreen Co

28 Total Invested Capital YOY % Growth Total Invested Capital 40, % 30, ,000 15% 1 10,000 5% 0 Total Invested Capital 12,390 14,327 16,373 18,438 20,390 22,612 26,081 29,802 34,031 36,242 39,187 YOY % Growth 24.6% 15.6% 14.3% 12.6% 10.6% 10.9% 15.3% 14.3% 14.2% 6.5% 8.1% Walgreen Co

29 Return on Invested Capital Return on Average Invested Capital 12% 1 8% 6% 4% 2% ROAIC 10.4% % 10.1% 10.7% 10.5% 10.8% 10.1% 8.8% 8.3% 9. NOPAT 1,135 1,309 1,488 1,691 1,981 2,215 2,558 2,765 2,769 2,890 3,375 Total Invested Capital 11,949 14,327 16,373 17,187 19,895 22,197 25,202 29,719 33,516 36,230 39,174 AVG. Invested Capital 10,948 13,138 15,350 16,780 18,541 21,046 23,699 27,461 31,618 34,873 37,702 Walgreen Co

30 Free Cash Flow ($ in Millions) Free Cash Flow (Cash Flow from Operations - Capital Expenditures) 3,000 2,500 2,000 1,500 1, ,000 FCF (518) , ,184 2,730 2,430 Walgreen Co

31 Stock Price P/E Ratio Annual Stock Price History vs P/E Ratio FY Q FY 2011 $60 50 $50 40 $40 30 $30 20 $20 $10 10 $ Walgreen Co

32 Stock Price S&P 500 Index Monthly Stock Price History vs S&P 500 Index FY FY 2005 $50 $40 $30 1,300 $20 $10 $0 FY 2000 FY 2001 FY 2002 FY 2003 FY 2004 FY Walgreen Co

33 Stock Price S&P 500 Index Monthly Stock Price History vs S&P 500 Index FY FY 2011 $50 $40 $30 1,300 $20 $10 $0 FY 2006 FY 2007 FY 2008 FY 2009 FY 2010 FY Walgreen Co

34 Investor Relations Contacts Rick J. Hans, CFA Divisional Vice President Investor Relations & Finance (847) Investor Relations Website (QR Code): Lisa Meers, CFA Manager of Investor Relations (847) Nicholas Zangler Senior Financial Analyst (847) To provide you with the most useful content, please share your feedback with us. Walgreen Co